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Chronic urogenital schistosomiasis can lead to squamous cell carcinoma of the bladder. The 
International Agency for Research on Cancer classifies the infection with S. haematobium as a group 
1 carcinogen, a definitive cause of cancer. By contrast, hepatointestinal schistosomiasis due to the 
chronic infection with S. mansoni or S. japonicum associated with liver periportal fibrosis, does not 
apparently lead to malignancy. The effects of culturing human epithelial cells, HCV29, established from 
normal urothelium, and H69, established from cholangiocytes, in the presence of S. haematobium 
or S. mansoni eggs were investigated. Cell growth of cells co-cultured with schistosome eggs was 
monitored in real time, and gene expression analysis of oncogenesis, epithelial to mesenchymal 
transition and apoptosis pathways was undertaken. Schistosome eggs promoted proliferation of 
the urothelial cells but inhibited growth of cholangiocytes. In addition, the tumor suppressor P53 
pathway was significantly downregulated when exposed to schistosome eggs, and downregulation 
of estrogen receptor was predicted in urothelial cells exposed only to S. haematobium eggs. Overall, 
cell proliferative responses were influenced by both the tissue origin of the epithelial cells and the 
schistosome species.
The blood flukes Schistosoma japonicum and S. mansoni are agents of hepatointestinal  schistosomiasis in East 
Asia, Africa, northeastern South America and the Caribbean, whereas S. haematobium causing urogenital schis-
tosomiasis (UGS) is present through Africa and the Middle East. It is estimated that 4.5 to 70 million disability 
adjusted life years (DALYs) are lost due to schistosomiasis1, and of >100 million cases of UGS in sub-Saharan 
Africa, 70 million show hematuria, 18 million major bladder pathology, and 10 million hydronephrosis that 
would eventually lead to kidney damage2,3. Many of the eggs of S. haematobium become trapped in host tissues, 
in particular urogenital organs, leading to inflammation and eventually squamous cell carcinoma of the bladder 
(SCC)4. Accordingly, and based on convincing epidemiological and pathophysiological findings, UGS has been 
classified as group 1 carcinogen by the International Agency for Research on Cancer5, although the cellular and 
molecular mechanisms underlying this infection-related carcinogenic process remain unclear. Women with UGS 
may suffer from female genital schistosomiasis (FGS)6 as consequence of the schistosome egg deposition in the 
uterus, cervix, vagina and vulva. Moreover, FGS has been associated with female infertility7 and increased sus-
ceptibility to HIV8.
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Schistosome eggs in the bladder wall release metabolites, presumably to facilitate the egress to the lumen 
and subsequently to the external environment to propagate the transmission cycle. Mass spectrometric analysis 
of urine during UGS has revealed estrogen-like metabolites, catechol estrogen quinones (CEQ)-DNA-adducts 
and novel metabolites derived from 8-oxo-7, 8-dihydro-2′- deoxyguanosine (8-oxodG)9 representing potential 
bladder carcinogens that may directly damage the DNA, leading to somatic mutations in oncogenes and tumor 
suppressors10,11. By contrast, S. mansoni dwells in the mesenteric vessels releasing eggs that embolize within the 
presinusoidal capillary beds of the liver, inducing periportal fibrosis and portal hypertension. Hepatointestinal 
schistosomiasis does not apparently lead to cell malignant transformation in these organs5.
Epithelial carcinomas are typically classified as conventional and nonconventional carcinomas12; 90% of 
epithelial carcinomas are of the conventional type and result from either papillary or flat in situ lesions, while 
nonconventional carcinomas include SCC, adenocarcinoma, and small cell carcinoma. SCC of the bladder is 
characterized by invasive cells containing desmosomes with keratin formation12. Research of UGS-induced blad-
der cancer is challenging due to the absence of laboratory animal models that mirror the human disease; in 
rodent models the vast majority of S. haematobium adult worms reside in the mesenteric veins. Recently, a mouse 
model was developed by injecting eggs of S. haematobium into the bladder wall of mice provoking egg-associated 
pathogenesis similar to the human condition13,14. In addition, premalignant lessons associated with epithelial to 
mesenchymal (EMT)-like profiles occurred following co-administration of nitrosamine in this model15.
In this study, responses of urothelium (HCV29 cells) and bile duct epithelium (H69 cells) to eggs of either 
S. haematobium or S. mansoni were investigated. Cells were cultured in the presence of schistosome eggs, 
and cellular proliferation monitored in real time using the xCELLigence system16. Increased proliferation of 
urothelial cells was evident when exposed to schistosome eggs, in particular to S. haematobium eggs. On the 
other hand, eggs of both schistosome species induced cell death of cholangiocytes. These phenotypic effects 
were associated with dysregulation of genes involved in oncogenesis, epithelial-mesenchymal transition and 
apoptosis pathways. Future studies to decipher cellular and/or molecular mechanisms underlying the associa-
tion between UGS and bladder cancer will contribute to the discovery of new interventions for this neglected 
tropical disease-related cancer.
Results
Schistosome eggs promoted growth of urothelial cells but inhibited cholangiocytes. A real-
time cell proliferation assay was employed to measure the effect of co-culturing schistosome eggs with two 
informative human epithelial cell lines. Although we have previously studied human cholangiocyte cells H69 
employing the xCELLigence Real Time Cell Assay17, we had not quantified the proliferation of the human urothe-
lial cell line HCV29 using this approach. It is critical to set up a priori the conditions for cell proliferation analysis 
for every new cell line in the laboratory mediated xCELLigence, even though the same cell line has been already 
analyzed by others18. Therefore, cell titration experiments were undertaken in order to establish tractable assay 
parameters, including seeding cell density (Fig. S1). Notably, regardless of the initial number of seeded cells, all 
the tested conditions showed a delay of at least ~24 hours before the cell index (CI) started to increase, with 20,000 
cells per well being the condition that reached a CI of ~3.0 within ~20 hours after it started to increase. Therefore, 
a seeding cell density of 20,000 cells per well was used in subsequent analyses.
HCV29 cells were seeded in E-plates, and cultured until the CI reached ~1.0. Subsequently, the cells were 
starved for two to four hours in 1/20 diluted medium before being co-cultured with schistosome eggs. Within 
~10 hours following addition of the eggs, proliferation of the cells accelerated, in an egg-concentration depend-
ent manner in comparison to cells cultured without schistosome eggs. Eggs of both S. mansoni and S. haema-
tobium induced cell proliferation, although eggs of S. haematobium induced higher proliferation, i.e. ~30% 
Figure 1. Proliferation of urothelial cells and cholangiocytes in response to schistosome eggs, monitored in 
real time using the xCELLigence system. Non-contact co-culture of Schistosoma mansoni and S. haematobium 
eggs with HCV29 cells (Panel A) or H69 cells (Panel B) over time after the addition of the eggs. Cell growth is 
expressed as percentage of the Normalized Cell Index of cells co-cultured with eggs compared with control cells 
(control cell growth rate = 100%). All curves represent the averages of at least three technical replicates for the 
experiment and standard deviations are shown as error bars at each data point. Blue and red asterisks indicate 
levels of significance (P ≤ 0.01) of growth ratios of cells cultured with S. mansoni and S. haematobium eggs, 
compared to control cells cultured in the absence of eggs, respectively. Sm live: S. mansoni live eggs; Sm heat-
killed: heat-killed S. mansoni eggs; Sh live: S. haematobium live eggs; Sh heat-killed: heat-killed S. haematobium 
eggs.
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versus ~10% by eggs of S. haematobium and S. mansoni, respectively (Figs 1A and S2A). Notably, heat-killed 
eggs showed similar effects to live eggs on HCV29 cell proliferation (Fig. 1A). Similarly, H69 cells were 
co-cultured in the presence of schistosome eggs. In contrast to HCV29, schistosome eggs (live or dead) inhib-
ited cell proliferation of cholangiocytes (Figs 1B and S2B). Although the S. haematobium eggs briefly induced 
cell proliferation of H69 cells between ~15 to 20 h post-incubation, eggs of both species overall reduced cell 
growth by ≥30% (Fig. 1B). The cell proliferation inhibition of H69 cells was evident by 24 h post-incubation 
for both schistosome species.
To summarize, the effect of the eggs on cell proliferation depended mainly on the cell type, i.e. cholangiocytes 
or urothelial, rather than on the schistosome species; however, S. haematobium eggs induced more proliferation of 
HCV29 cells than S. mansoni eggs (Fig. 1A), and a brief increase of H69 cell proliferation before the cell inhibition 
was evident for both schistosome species. Surprisingly, this proliferative effect was independent of egg viability. 
However, a cell proliferation increment was also evident when HCV29 cells were exposed to excretory-secretory 
products (ES) previously collected from either S. mansoni or S. haematobium eggs (Fig. S3), strongly suggesting 
that the proliferative effect was not due to the presence of a ‘foreign body’ inducing a non-specific effect. Overall, 
the same trend was evident for both tested conditions, i.e. eggs and ES. When ES products collected from both 
schistosome egg species were employed in the assay the cell proliferation increased in a concentration-dependent 
manner. Evidently 10 μg/ml, the highest tested concentration, induced the strongest proliferation, thus the cells 
started to die sooner. Remarkably, this effect was more pronounced when S. haematobium was employed (Fig. S3). 
Further studies comparing the compositions of the S. mansoni and S. haematobium ES products may lead to a 
better understanding of these differences.
Gene expression dysregulation was schistosome species- and contact time- dependent. The 
effect of schistosome eggs on cell proliferation of HCV29 was evident within the first 10 hours after the incuba-
tion and persisted beyond 24 hours. Therefore, guided by the xCELLigence findings we decided to analyze the 
gene expression of cells at two time points post-incubation; cells exposed for 2 hours (‘early time point’) looking 
for early events in gene expression dysregulation, and cells exposed for 24 hours. Two gene qPCR arrays were 
employed to detect ‘early’ and ‘late’ molecular events that might be associated with high cell proliferation of the 
urothelial HCV29 cells co-cultured with schistosome eggs; (1) oncogenes and tumor suppressor gene array, and 
(2) epithelial to mesenchymal transition (EMT) gene array. The output raw data from these two gene arrays were 
combined in the final analysis. Whereas urothelial cells rapidly displayed gene dysregulation two hours after 
the addition of S. mansoni eggs, S. haematobium only induced the upregulation of the transcriptional repressor 
FOXD3 (Fig. 2A). At 2 hours, the early time point, S. mansoni eggs co-cultured with urothelial cells triggered the 
upregulation of 28 genes and downregulation of a single gene (B2M - a component of MHC class I molecules.) 
Figure 2. Schistosome eggs induced dysregulation of oncogenes, tumor suppressors and EMT-related genes in 
HCV29 cells over time. Volcano plots of HCV29 cell gene response to non-contact co-culture with S. mansoni 
or S. haematobium eggs as indicated, for 2 (Panel A) or 24 (Panel B) hours. Gene expression was measured using 
qPCR gene arrays designed to assess oncogenesis- and EMT- associated transcripts. Significantly dysregulated 
(P < 0.05) genes with >±1.5-fold-change, are shown. Panel C. Venn diagram compiled only with the HCV29 
cell culture conditions that share differentially expressed genes (DEG) – only upregulated genes were shared 
among the 3 indicated conditions. (Table S2 includes the complete set of DEG indicated in the Venn diagram).
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(Fig. 2A and Table S1). Tumor Necrosis Factor (TNF) and SNAI3 genes were the most upregulated genes in 
HCV29 cells co-cultured with S. mansoni eggs with fold changes of 9.72 and 11.01, respectively. Notably, the 
estrogen receptor 1 gene (ESR1) was upregulated 2.68-fold in HCV29 cells co-cultured with S. mansoni eggs at 
the ‘early’ time point.
Urothelial cells exposed to S. mansoni eggs for 24 h (‘late time point’) displayed 29 dysregulated genes (Fig. 2B 
and Table S1). Interestingly, at this late time point, S. mansoni eggs induced downregulation of p53 tumor sup-
pressor gene by 1.92-fold (Fig. 2B, shown as TP53, and Table S1). The expression of 7 genes dysregulated at 
the early time point remained altered at the late time point (ACTB, AKT1, B2M, RGS2, RUNX1, SH3PXD2A, 
SNAI2) (Fig. 2B and Table S1). Although at the early time point a single gene was upregulated, at the late time 
point 33 genes were dysregulated by S. haematobium eggs (Fig. 2B). Seven genes were dysregulated by both S. 
mansoni and S. haematobium eggs at the late time point (ACTB, AKT1, SMAD2, SNAI2, VIM, WNT5B, ZEB2) 
(Fig. 2B and Table S1). It is noteworthy that S. mansoni eggs upregulated 3.39 folds the expression of Insulin Like 
Growth Factor 2 Receptor (IGF2R) in urothelial cells at both time points examined, the same gene was 2.57-fold 
downregulated by S. haematobium (Fig. 2B and Table S1). Overall, 64 genes were dysregulated by S. mansoni and 
S. haematobium eggs when co-cultured with urothelial cells (Fig. 2B and Table S1). Cell culture conditions that 
displayed overlapped differentially expressed genes are shown in a Venn diagram (Fig. 2C). Surprisingly, rela-
tively few upregulated genes were shared between early and late time points in HCV29 cells exposed to S. mansoni 
eggs, i.e. RGS2, SH3PXD2A, and RUNX1. Three genes, PTK2, AKT1, and SNAI2 were significantly upregulated 
in cells exposed to both schistosome species; S. mansoni eggs at both time points and S. haematobium eggs at the 
late time point. (Fig. 2C, and Table S2). No downregulated genes were shared among the different cell culture 
conditions for HCV29 cells (Table S2).
Given schistosome eggs inhibited the cell growth of the H69 human cholangiocyte cell line, an effect that 
became evident after ~24 hours post-incubation (above), an apoptosis gene array was employed to evaluate the 
gene expression dysregulation in cells exposed to schistosome eggs for 24 hours. Twelve genes were dysregulated 
when the cells were co-cultured with S. mansoni and S. haematobium eggs (Fig. 3A). Whereas both TNFSF10 and 
TP73 genes were downregulated by both schistosome species (Fig. 3B), S. mansoni eggs induced upregulation 
of three genes, i.e. BID, CYCS and GADD45A, and S. haematobium eggs induced downregulation of TNFRSF9, 
TNFSF10 and TP73 (Table S3).
Colorectal cancer signaling pathway was significantly dysregulated by S. mansoni but not S. 
haematobium eggs. In order to detect significantly altered pathways in cells exposed to schistosome eggs 
a functional pathway analysis of differentially expressed genes was performed. The functional pathway analysis 
Figure 3. Schistosome eggs induced dysregulation of apoptosis-related genes in H69 cells. Volcano plot of 
the H69 cell gene response to non-contact co-culture with S. mansoni or S. haematobium eggs as indicated 
for 24 hours. Gene expression was measured using qPCR gene arrays designed to assess apoptosis-associated 
transcripts. Significantly dysregulated (P < 0.05) genes with >±1.5-fold-change, are shown. (Table S1 includes 
the complete data set of gene expression changes.) Panel B. Venn diagram compiled only with the H69 cell 
culture conditions that share differentially expressed genes (DEG) – only downregulated genes were shared 
between the two conditions indicated.
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takes into consideration the differentially expressed genes detected in the gene expression arrays employed 
herein (see Methods) and determines which biological functions and canonical pathways are significantly 
associated with these dysregulated genes. At the early time point, i.e. 2 h after incubation of urothelial cells in 
the presence of S. mansoni eggs, genes associated to colorectal cancer metastasis signaling pathway were upreg-
ulated (Fig. 4)19. This pathway was significantly upregulated (with a positive z-score of 7.5 and P = 2.58 × 10−08) 
showing a cascade of significantly overexpressed genes (Table 1) including TNF, a pro-inflammatory cytokine 
implicated in colorectal cancers20 upregulated 9.72 fold, the oncogenes MYC and JUN upregulated more than 
4 fold, among others (Table 1). Interestingly, urothelial cells co-cultured with S. mansoni eggs or S. haemato-
bium eggs for 24 hours showed upregulation of WNT5B or both WNT5a and WNT5b, respectively (Fig. 2B,C). 
Notably, upregulation of WNT5a and WNT5b has been implicated in colon rectal cancer via non-canonical 
WNT signaling pathway21 However, the signaling pathway analysis did not support any significant correlation 
between the upregulated wnt genes in cells cultured with schistosome eggs and colorectal cancer pathway 
24 hours after exposure.
Tumor suppressor P53-associated pathway was downregulated by both S. mansoni and S. 
haematobium eggs. The tumor suppressor P53-associated pathway was significantly downregulated in 
urothelial cells exposed to both S. mansoni and S. haematobium eggs. Notably, different sets of genes within the 
pathway were altered by the two schistosome species (Fig. 5 and Table 2), i.e. S. mansoni reduced the expression 
of P53 (fold change of −1.92, P = 0.0033), E2F1 (fold change of 2.75, P = 0.0268) and SERPINB5 (fold change 
of −3.09 and P = 0.0032) genes, whereas S. haematobium induced downregulation of ATM (fold change of 
−2.69, P = 0.0433), MDM2 (fold change of −2.64, P = 0.0187), PML (fold change of −2.50, P = 0.0231) and the 
BCL2-Associated X (BAX) (fold change of −2.22 and P = 0.0178) (Table 2). Two of these proteins were selected 
to validate the gene array findings at the protein level, i.e. ELISAs were performed to quantify P53 and BAX in 
urothelial cells co-cultured in the absence or presence of S. mansoni or S. haematobium eggs for 2 or 24 hours 
(Fig. S4). In concordance with the gene array findings, no significant changes were observed at 2 hours after 
egg-exposure for both BAX and P53 proteins among the groups of cells exposed to no eggs, S. mansoni or S. hae-
matobium eggs (Fig. S4). As expected, at 24 hours post-exposure no significant differences were observed between 
S. mansoni egg-exposed cells (Sm 24 hr) and control (Control 24 hr) for BAX protein; however, a higher level of 
Figure 4. Significant dysregulation of genes involved in Colorectal Cancer Signaling Pathway in urothelial cells. 
The pathway was significantly dysregulated at early time point in S. mansoni eggs co-cultured HCV29 cells, and 
all the perturbed genes were upregulated (genes colored in red). Adapted from map05210 Colorectal cancer, 
KEEG Database63–65.
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this protein was quantified in cells exposed to S. haematobium eggs (Sh 24 hr). Similar findings were obtained for 
P53 (Fig. S4).
Estrogen receptor and beta-estradiol altered by schistosome eggs. Notably, the estrogen receptor 
(ESR1) was upregulated 2.68-fold (P = 0.000812) in urothelial cells co-cultured with S. mansoni eggs at the early 
time point (Fig. 2A), but not with S. haematobium eggs. However, the upstream regulatory analysis (URA) of 
differentially expressed genes predicted both the estrogen receptor and beta estradiol to be inhibited in urothelial 
cells co-cultured with S. haematobium eggs for 24 hours, but not with S. mansoni eggs (Fig. 6).
Discussion
Infectious diseases are associated with >20% of cancers in the developing world22. About a dozen patho-
gens including human papillomavirus, Epstein-Barr virus and hepatitis B virus are well known agents of 
cancer-associated infections. Infections with several parasitic flatworms are also associated with carcinogen-
esis5,22. The International Agency for Research on Cancer (IARC) categorizes infection with the food-borne 
trematodes Opisthorchis viverrini and Clonorchis sinensis, both liver flukes, and the blood fluke Schistosoma 
haematobium as group 1 biological carcinogens5. More recently we have shown that the chronic infection 
with the liver fluke Opisthorchis felineus might also be associated with liver cancer23. In addition to parasit-
ism directly damaging development, health and prosperity of infected populations, chronic infection with 
these liver and blood flukes leads to cholangiocarcinoma (CCA) (bile duct cancer) and squamous cell car-
cinoma (SCC) of the urinary bladder, respectively5. By contrast, chronic infection with phylogenetic rela-
tives, including trematodes of the phylum Platyhelminthes which are major pathogens, has not been proven 
to be carcinogenic. These noteworthy differences suggest that either helminth-specific metabolites contribute 
to tumorigenesis and/or that certain tissues or organs directly or indirectly exposed to the parasite and/or 
parasite-derived metabolites are particularly susceptible to infection-induced malignancy24. Consequently, 
aiming to compare/contrast the effect of eggs of a well-established carcinogenic species of schistosome, i.e. S. 
haematobium, with eggs of a non-carcinogenic schistosome, i.e. S. mansoni, established epithelial cells derived 
from two discrete tissues, HCV29, from human urothelium, and the H69, from cholangiocytes, were cultured 
in the presence of eggs of S. haematobium or S. mansoni. Remarkably, epithelial cells from urinary and biliary 
tract displayed differential responses to S. haematobium and S. mansoni. The proliferative response and asso-
ciated changes in signaling pathways responses of these cells appear to have been influenced by both the tissue 
origin of the epithelial cells and the schistosome species.
Both S. haematobium and S. mansoni eggs stimulated cellular growth in HCV29 urothelial cells when com-
pared to control cells in the absence of schistosome eggs. Moreover, genes strongly associated with cell migration 
(PTK2 and VIM)25, proliferation (AKT1)26, inhibition of apoptosis (SNAI2)27, and carcinogenesis mediated by 
the TGFβ signaling pathway (SMAD2 and ZEB2)28 were upregulated in cells exposed to both species. Therefore, 
it is tempting to speculate that the carcinogenicity of the chronic infection with these parasites not only depends 
on the schistosome species but also the host tissue exposed to antigens and excretory-secretory products from 
the eggs. More studies, including in vitro cell co-culture experiments with informative cell lines derived from 
different tissues will contribute to the resolution of this issue. Several cancer-inducing parasites stimulate cellular 
proliferation when co-cultured with mammalian cells. Excretory-secretory products (ES) from the liver flukes, O. 
Gene name (ID)
HCV29 cell line*
Gene description ReferenceSh eggs Sm eggs
TNF
(Tumor Necrosis Factor) NS ↑ 9.72 (P = 0.031) 2 h
Pro-inflammatory cytokine implicated in colorectal cancers, 
associated with tumor growth, proliferation and metastasis
19,20,66
RUNX1
(Runt Related Transcription Factor 1) NS ↑ 4.59 (P = 0.042) 2 h and 24 h
Transcription factor with tumor suppressor functions associated 
with growth promotion of skin, oral, breast and ovarian tumor cells.
67
MYC
(Proto-Oncogene) NS ↑ 4.01 (P = 0.044) 2 h
Transcription factor involved in cell proliferation, inhibition of cell 
differentiation and apoptosis. Over expressed in over 50% of all 
cancers, is considered a metastasis marker.
68,69
JUN
(Proto-Oncogene, AP-1 Transcription Factor Subunit) NS ↑ 3.34 (P = 0.029) 2 h
Transcription factor involves in cell cycle progression, cell survival, 
transformation and proliferation. Over expression of JUN has been 
related to p53 repression.
70
NFKB1
(Nuclear Factor Kappa B subunit 1) NS ↑ 2.82 (P = 0.039) 2 h
Transcription factor responsible for the regulation of ~300 genes 
involved with immune, growth and inflammation processes. Over 
expressed in many cancer types including colorectal, breast, liver, 
prostate and kidney.
71,72
SRC
(Proto-Oncogene, Non-Receptor Tyrosine Kinase) NS ↑ 2.72 (P = 0.006) 2 h
Proto-oncogene over expressed in colorectal, pancreas and 
prostate cancer, implicated in tumor progression, cell migration, 
angiogenesis, and metastasis.
73,74
BCL2
(Apoptosis regulator) NS ↑ 2.69 (P = 0.035) 2 h
Anti-apoptotic regulator involved in several lymphomas. When 
over expressed, it has been associated with low survival of diffuse 
large B-cell lymphoma
75–77
Table 1. Differentially expressed genes associated with Colorectal Cancer Signaling Pathway identified 
in HCV29 cells exposed to eggs of Schistosoma haematobium (Sh) or S. mansoni (Sm). *Fold change and P 
value, upregulation (↑), downregulation (↓), NS: non-significant. The exposure time of cells co-cultured with 
indicated schistosome eggs (2 h and/or 24 h) for which the specific gene expression dysregulation was detected 
is indicated after  the Fold change.
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viverrini and C. sinensis promoted growth of mouse fibroblast NIH-3T3 and human kidney embryonic epithelial 
cells HEK29329,30. S. haematobium egg antigens induced cell proliferation, apoptosis inhibition and altered cell 
migration in vitro31. In addition, cells pretreated with S. haematobium egg antigens induced tumor development 
when injected in immunodeficient mice32. Moreover, intravesical administration of S. haematobium total antigen 
into CD-1 mice induces a high incidence of urothelial dysplasia33. Other reports reveal that human urothelial and 
bovine endothelial cells exhibit increased proliferation following exposure to soluble egg antigen of S. haemato-
bium34. S. mansoni also promotes proliferation of some cell lineages as granulomas are a rich source of cytokines 
and growth factors and stimulates tissue proliferation and fibroplasia in mammalian tissue35 and total antigen 
from S. mansoni egg stimulates fibroblasts in vitro36. S. mansoni soluble egg antigens induce proliferation of H69 
cells and murine cholangiocytes37. However, herein we showed that when each of the species of schistosome eggs 
were co-cultured with the H69 cholangiocyte cell line a consistent decrease in cellular proliferation, even using 
heat-inactivated schistosome eggs, was observed.
Schistosome soluble egg antigens stimulate cellular proliferation of murine splenocytes whereas higher con-
centrations induce apoptosis in a dose-dependent fashion38. Antigens from both S. japonicum and S. mansoni 
negatively regulate hepatic stellate and CD4 + ve T cells39,40. Some of the disparities among these reports may 
relate to methods to prepare egg-secreted proteins (ESP) or soluble egg antigens (SEA). Egg-secreted proteins 
differ significantly when compared to soluble egg antigen in terms of protein sizes and the presence of proteases 
that are found in ESP but not in SEA41. In addition, we cannot completely rule out the effect observed in the cur-
rent study was due to a foreign body co-cultured with the cells. However, we speculate that if that was the case 
the same unspecific effect should have been observed on both cell lines regardless the schistosome species. In this 
regard, the findings showed (1) species-specific effects on the same cell line, e.g. even though both schistosome 
eggs stimulated cell proliferation of HCV29, S. haematobium eggs induced more proliferation than S. mansoni 
eggs, and (2) differences on effect intensities between live and heat-killed eggs, e.g. even though similar effects 
were induced by heat-killed or live S. mansoni eggs, the latter clearly had a stronger effect on both stimulating 
HCV29 cells and inhibiting H69 cells. By contrast, S. haematobium heat-killed eggs slightly induced a stronger 
effect on the cells compared to live eggs. These differences induced by the two schistosomes on different cells 
presumably would not have been detected if the effects were due to just the presence of a foreign inert body. Last, 
there was increased proliferation when the cells were cultured in the presence of ES only collected from the eggs, 
i.e. no eggs were used in the experiment. This strongly suggested the effect was not due to the presence of an inert 
body in the experimental setting.
The Ingenuity Pathway Analysis (IPA) identified the colorectal metastasis-signaling pathway significantly 
dysregulated in urothelial HCV29 cells co-cultured with S. mansoni eggs, but not with S. haematobium eggs 
after being co-cultured for 2 hours. In contrast, exposure of the urothelial cells to S. haematobium eggs for 
24 hours induced upregulation of WNT5a and WNT5b. Although not significantly associated to Colorectal can-
cer pathway in our analysis, these genes have been involved in carcinogenesis, including colorectal cancer via 
non-canonical WNT signaling pathway21. On the other hand, S. mansoni eggs induced upregulation of these same 
genes (WNT5a and WNT5b) at both time points. A link has been proposed between infection with S. mansoni 
and colorectal cancers42. IARC classifies infection with S. haematobium as a group 1 carcinogen, whereas infection 
with S. mansoni is included in group 3, indicating there is insufficient evidence to determine its carcinogenicity5. 
Nonetheless, schistosomal colitis is commonly associated with earlier onset of multicentric colorectal cancer, and 
notably mucinous adenocarcinoma often presents at an advanced stage in regions endemic for infection with S. 
mansoni43. Moreover, a higher incidence of altered p53 expression with schistosomal colitis-associated colorectal 
cancer suggests an association between schistosomiasis and alterations in p53 activation43. Intestinal schistoso-
miasis caused by S. japonicum exhibits a geographic distribution that overlaps with populations affected by early 
onset of colon cancer in China44. In addition, several genes were upregulated in HCV29 cells at the early time 
point when exposed to S. mansoni eggs. Interestingly, only β-2 microglobulin (B2M) was downregulated 1.5 folds 
and more than 3 folds 2- and 24-hours post-exposure, respectively. B2M belongs to the major histocompatibility 
complex (MHC) class I45. Because B2M is not only markedly downregulated in colorectal cancer tissue compared 
with normal mucosa46, but also plays a prominent role in antigen presentation, it is tempting to speculate that its 
downregulation might impede host clearance of the fluke infection.
Surprisingly, significantly dysregulated pathways were not identified in HCV29 cells co-cultured with S. hae-
matobium eggs at the early time point (2 hours); FOXD3 was the only gene to be upregulated. This transcription 
factor is a member of the forkhead family with a key role in progenitor cell pluripotency and differentiation, 
and regulation of cellular transition from naïve to primed pluripotency47. FOXD3 is upregulated in renal can-
cer and endometrial tumors and downregulated in cancers of the colon and cervix48. Remarkably, by 24 hours 
post-exposure not only were  many more genes were upregulated in HCV29 cells exposed to S. haematobium 
eggs, but also the number of dysregulated genes outnumbered those dysregulated by S. mansoni eggs. It is tempt-
ing to speculate that this is related to the oncogenic nature of S. haematobium infection, although further studies 
are needed to clarify this point. Several genes dysregulated by either or both species of schistosomes have been 
linked to inflammation and schistosomiasis-associated disease but have not been associated with cancer, at least 
in a direct manner, e.g. Tumor Necrosis Factor (TNF) or Nuclear Factor Kappa B subunit 1 (NFK-B). Notably, 
elevated TNF levels can occur during acute schistosomiasis and severe pathology is associated with elevated cir-
culating levels of TNF and TNF receptors (TNFRs). Moreover, TNF might be involved in maintaining S. mansoni 
adult viability in the portal system49, and would be required by the parasite for egg-laying and egg-excretion from 
the host50. Consistent with this hypothesis, here TNF was upregulated >9 folds by eggs of S. mansoni but not S. 
haematobium.
Estradiol-like metabolites have been characterized both in S. haematobium parasites and in urine during 
urogenital schistosomiasis9. We have recently predicted pathways and enzymes that are involved in the produc-
tion of these metabolites and emphasized their potential effects on the dysregulation of the tumor suppressor 
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gene p53 expression during urogenital schistosomiasis (reviewed in51). Mutations of p53 in the context of 
UGS-induced bladder cancers from Angola along with sialylated glycans have been suggested as surrogate 
biomarkers of bladder carcinogenesis associated with S. haematobium infection highlighting links between 
infection and cancer development52. Eggs of S. haematobium express the sialyl-Lewis sLea and sLex antigens in 
mimicry of human leukocytes glycosylation, which may play a role in the colonization and disease dissemina-
tion. Tumor suppressors including P53 and genes involved in the P53 pathway and metalloprotease inhibitors 
were downregulated when exposed to schistosome eggs. In bladder cancers, recurrent mutations occur in >30 
other genes involved in cell proliferation, differentiation, genetic stability, and specifically cell-cycle regulation, 
chromatin regulation, and kinase signaling pathways53. The downregulation of p53 is characteristic of cancers 
in general and SCC of the bladder in particular. In this regard, we found the tumor suppressor P53-associated 
pathway significantly downregulated in urothelial cells exposed to both S. mansoni and S. haematobium eggs. 
The P53 signaling pathway is responsible for hundreds of downstream transcriptional targets involved in the 
inhibition of cell growth, induction of apoptosis and regulation of metabolism in response to oncogene acti-
vation and other signals54. In a mouse model of infection-related bladder cancer, S. haematobium egg-induced 
bladder urothelial abnormalities were dependent on p53 in a host sex dependent manner10,14. We decided 
to validate the dysregulation of P53 and BAX proteins performing ELISA assays, key genes detected in our 
dataset involved in carcinogenesis. The protein quantification for BAX and P53 concurred with the gene array 
data 2 hours after exposure. In addition, as in the gene array data BAX protein was not dysregulated in S. 
mansoni egg-exposed cells at 24 hours post-exposure. However, BAX and P53 proteins were over expressed in 
S. haematobium egg-exposed cells and P53 was not down-regulated in S. mansoni egg-exposed cells. Among 
confounders that might explain the unexpected differences, different batches of eggs and cells employed in 
the two experiments, which were separated widely in time. In addition, recent studies highlight the lack of 
correlation between mRNA and protein levels for many genes, including those involved in carcinogenesis. This 
would reflect the complexity of the gene expression regulation  at several levels including post-transcriptional 
regulation of mRNA and post-translational modifications of proteins55,56. The latter could also explain the 
inconsistencies between the qPCR gene array signals for the bax and p53 genes and concentrations of BAX 
and P53 in cells exposed to schistosome eggs. Future studies involving high throughput transcriptomic and 
proteomic analyses from cells exposed to eggs and excretory-secretory products from eggs may clarify these 
contradictory findings.
Upstream regulatory analysis (URA) of differentially expressed genes (DEGs) predicted that the exposure of 
urothelial cells to eggs of S. haematobium but not S. mansoni downregulated expression of the estrogen receptor. 
This phenomenon was previously reported in other experimental models showing that an estradiol-like molecule 
antagonist to estradiol represses the transcriptional activity of the estrogen receptor (ER)57. We have reviewed 
how an estrogen-DNA adduct mediated pathway may be involved in the pathogenesis of the squamous cell car-
cinoma of the bladder associated with urogenital schistosomiasis58,59. Extracts of S. haematobium eggs induced 
tumor-like phenotypes in cultured cells and, in addition, estrogen-derived, reactive metabolites occurred in this 
pathogen and in sera during UGS including catechol estrogen quinones (CEQ) and CEQ-DNA-adducts9.
Figure 5. Significant dysregulation of P53 pathway in urothelial cells exposed to either S. haematobium or 
S. mansoni eggs for 24 hours. P53 pathway highlighting upregulated or downregulated genes in red or green, 
respectively. Genes affected by S. mansoni or S. haematobium are indicated by blue or red squares, respectively. 
Adapted from map04115 p53 signaling pathway, KEEG Database63–65.
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To conclude, H69 and HCV29 cells displayed differential responses to eggs of S. haematobium and S. mansoni, 
supporting the hypothesis that the carcinogenic nature of infection with S. haematobium is related to its interac-
tion with the specialized epithelium of the human bladder. Proliferative responses of these cells were influenced 
by both the tissue origin of the epithelial cells and the schistosome species. Focused studies of the molecular 
mechanisms underlying the association between UGS and SSC of the bladder are expected to enhance prospects 
to manage this neglected tropical disease-related cancer.
Materials and Methods
Ethics statement. Male LVG hamsters were purchased from Charles River (Wilmington, MA) and main-
tained at the Biomedical Research Institute’s (BRI), Rockville, MD, animal facility accredited by the American 
Association for Accreditation of Laboratory Animal Care (AAALAC; #000779). BRI is a USDA registered ani-
mal facility (51-R-0050), and has an Animal Welfare Assurance on file with the National Institutes of Health, 
Office of Laboratory Animal Welfare (OLAW), A3080-01. Maintenance of hamsters exposed to Egyptian strain 
of S. haematobium cercariae and harvesting of tissues were approved by the BRI Institutional Animal Care and 
Use Committee. All procedures employed were consistent with the Guide for the Care and Use of Laboratory 
Animals.
Mice infected with the NMRI (Puerto Rican) strain of Schistosoma mansoni were supplied by BRI and main-
tained at The George Washington University (GW) following protocols approved by the GW Institutional Animal 
Case and Use Committee.
Schistosome eggs and excretory-secretory products (ES) from eggs. Isolation of eggs from liver 
of experimentally-infected rodents was performed as previously described60. In brief, 3–5 dissected livers from S. 
mansoni-infected mice, and 2–3 livers from S. haematobium-infected Syrian golden hamsters were briefly washed 
in 70% ethanol solution, chopped finely with a sterile scalpel blade and transferred to a 50 ml conical tube con-
taining 45 ml phosphate-buffered saline (1X PBS), 2% antibiotic-antimycotic solution (Life Technologies) and 
0.5% clostridial collagenase (Sigma). The minced livers were incubated with gentle shaking overnight at 37 °C, 
centrifuged at 400 g for 5 min, and washed with 1X PBS 3 times. After the last wash, the pellet was resuspended 
in 25 ml 1X PBS, passed successively through sterile 250 μm and 150 μm sieves, and the filtrate centrifuged at 
400 g for 5 min. The liver mixture filtrate mixture was centrifuged at 400 g for 5 min, the supernatant discarded 
and the pellet resuspended in 3 ml of 1X PBS, applied to a column of Percoll, prepared by mixing 8 ml of Percoll 
(GE Healthcare Bio-Science AB) with 32 ml of 0.25 M sucrose, and centrifuged at 800 g for 10 min. Liver cells and 
debris that remained on the top of the Percoll were removed with a Pasteur pipette. The schistosome eggs, which 
pelleted tightly at the bottom of the tube, were washed three times with 1X PBS to remove residual host tissues. 
Further purification was achieved by resuspending the eggs in 0.5 ml of 1X PBS and a second Percoll column, pre-
pared by mixing 2.5 ml of Percoll with 7.5 ml of 0.25 M sucrose. The eggs were pelleted, washed as before, counted 
and cultured in DMEM, 10% FBS and 2% antibiotic-antimycotic at 37 °C, 5% CO2. Egg viability was evaluated by 
hatching an aliquot of a few hundred eggs in water under light. When heat-killed eggs were included as controls, 
eggs were transferred to a 1.5 ml tube and incubated for 10 min at 80 °C in a heat-block. For excretory-secretory 
Gene name (ID)
HCV29 cell line* Gene description
ReferenceSh eggs Sm eggs
SERPINB5
(Serpin Family B, member 5) NS ↓ −3.09 (P = 0.003) 24 h
Inhibitor of cancer cell invasion, metastasis and angiogenesis. 
Under expression associated with breast, prostate, thyroid and 
skin tumors.
78
ATM
(Ataxia Telangiectasia Mutated, Serine/
Threonine kinase)
↓ −2.69 (p = 0.043) 24 h NS
Mediator in kinase cascade that controls DNA damage 
response, cell-cycle progression, DNA recombination and 
apoptosis. Its downregulation inhibits p53 and cell cycle arrest.
79,80
MDM2
(MDM2 Proto-Oncogene) ↓ −2.64 (P = 0.018) 24 h NS
Ubiquitin E3 ligase that degrades P53 is under the control of 
p53 in a regulatory feedback loop (Fig. 4)
81,82
PML
(Promyelocytic Leukemia) ↓ −2.50 (p = 0.023) 24 h NS
Nuclear protein involved in cell cycle progression, DNA 
damage response, and apoptosis, i.e. key regulator in the p53 
pathway. PML-deficient mice exhibit apoptotic defects.
83–85
BAX
(BCL2 Associated X, Apoptosis Regulator) ↓−2.22 (P = 0.017) 24 h NS
Major promoter of apoptosis is regulated by p53, it has been 
involved in tumorigenesis by interfering with cell death.
86
P53
(Tumor Protein P53 or TP53 as in Fig. 2) NS ↓ −1.92 (P = 0.003) 24 h
Tumor suppressor, a key transcription factor inhibiting cancer 
development, being inactivated in most tumors. It responds to 
cell stress by activating genes responsible for DNA repair, cell 
cycle arrest, anti-angiogenesis, apoptosis and autophagy
87,88
E2F1
(E2F Transcription Factor 1) NS ↑ 2.75 (P = 0.026) 24 h
Transcription factor that regulates cell cycle progression, 
involved in either oncogenesis or tumor suppression 
depending on cellular signals. E2F1 over expression associated 
with oncogenic transformation in rodent embryonic 
fibroblasts and tumorigenesis.
89,90
Table 2. Differentially expressed genes associated with P53 Signaling Pathway identified in HCV29 cells 
exposed to either eggs of Schistosoma haematobium (Sh) or S. mansoni (Sm). **Fold change and P value, 
upregulation (↑), downregulation (↓), NS, non-significant. The exposure time of cells co-cultured with 
indicated schistosome eggs (2 h and/or 24 h) for which the specific gene expression dysregulation was detected 
is indicated after  the Fold change.
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products (ES), eggs were washed 3 times in 1X PBS, resuspended in DMEM, 2% antibiotic-antimycotic solution 
and protease inhibitor cocktail (Amresco), and incubated in 2 ml of serum-free media in 12-well plates overnight 
at 37 °C, 5% CO2. The supernatant (i.e., ES) was collected, clarified by centrifugation at ~14,000 rpm, 4 °C, 30 min, 
transferred to a new tube where additional protease inhibitor cocktail was added and stored at −80 °C. Protein 
concentrations of ES was determined using the bicinchoninic acid assay (BCA kit, Pierce, Rockford, IL).
Human epithelial cell lines. The human cholangiocyte H69 cell line is a SV40-transformed human bile 
duct epithelial cell line derived from a normal liver61. The H69 cells were used between passages 10 and 30 and 
grown in H69 medium that included 43.82% DMEM medium (Dulbecco’s Modified Eagle’s Medium), 43.82% 
DMEM/Ham’s F12, 10% fetal bovine serum (FBS), supplemented with 1% adenine, 0.1% insulin, 0.1% epineph-
rine, 0.1% T3-T, 0.03% epidermal growth factor (EGF), 0.03% of a 4% hydrocortisone dilution in DMEM and 
1% penicillin/streptomycin (PS). The human HCV29 cell line is derived from non-malignant urothelium of the 
ureter62. The HCV29 cells, used between passages of 10 to 30, were maintained in DMEM supplemented with 10% 
FBS and 1% PS (complete DMEM). Passages of both cell lines were undertaken when the confluence reached 90% 
in a 75 cm2 flask in a 1/10 dilution using trypsin to dislocate cells. Both cell lines tested negative for mycoplasma 
(not shown).
Real time assessment of cell proliferation by xCELLigence system. Cellular proliferation of H69 
and HCV29 cells was assessed using the xCELLigence DP system (ACEA Biosciences, San Diego, CA, USA), 
designed to monitor events in real time by measuring electrical impedance across inter-digitated microelec-
trodes integrated on the bottom of tissue culture E-plates, see http://www.aceabio.com/main.aspx16. H69 cells 
were seeded at 5,000 cells/well in E-plates in H69 medium, cultured for one day, rinsed in 1X PBS and cultured in 
1/20 diluted H69 medium in 50% DMEM and 50% DMEM/Ham’s F12, containing 1% of PS, i.e. 0.5% FBS final 
concentration, as described17. For HCV29 cells a cell number titration experiment was first performed (Fig. S1), 
being 20,000 cells/well the selected number of cells for subsequent experiments. HCV29 cells were seeded in 
E-plates in complete DMEM medium, cultured for one day, rinsed with 1X PBS, and cultured in 1/20 diluted 
DMEM media. Both cell lines were fasted in 1/20 diluted medium for 4–6 h after which the cells were co-cultured 
with viable or heat-killed (below) schistosome eggs. The eggs were placed in a tissue culture insert transwell 
where the base of the insert is a polyethylene terephthalate (PET) membrane with a median pore size of 0.4 μm 
(ACEA catalog no. 06465382001). The transwell carrying the eggs were inserted into tissue culture plates were 
the cells were growing. Consequently, cells cultured on plastic in the tissue culture wells were exposed to the 
excretory-secretory products (ES) diffusing from the insert chamber carrying the eggs. For experiments where 
HCV29 cells were cultured in the presence of ES previously collected from S. mansoni or S. haematobium eggs as 
described above, the cells were fasted in 100 μl of 1/20 diluted medium for 4–6 hours in the xCELLigence platform 
after which 100 μl of 2X ES of the desire final concentration, i.e. no ES (control), 10, 2 or 0.4 μg/ml, was added 
Figure 6. Upstream regulatory analysis (URA) of differentially expressed genes (DEGs) predicted the estrogen 
receptor and beta-estradiol (P < 0.05) to be inhibited in HCV29 cells co-culture for 24 h with S. haematobium 
eggs. Panel A. Significantly upregulated genes are shown in red. These genes, negatively regulated (T-symbol) 
by the estrogen receptor, were found to be upregulated in HCV29 cells co-cultured with S. haematobium eggs 
for 24 hours; red dashed lines indicate that these genes were activated. Therefore, the URA analysis significantly 
predicted the estrogen receptor as an inhibited upstream regulator of this set of genes in this dataset. Panel 
B. Significantly downregulated genes are shown in green. These genes, positively regulated (arrow) by 
beta-estradiol, were found to be downregulated in HCV29 cells co-cultured with S. haematobium eggs for 
24 hours; blue dashed lines indicate that these genes were inhibited in our dataset. Therefore, the URA analysis 
significantly predicted beta-estradiol as an inhibited upstream regulator of this set of genes in the dataset.
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to the well. The cellular growth was monitored in real time for at least 60 hours. The normalized cell index (CI), 
obtained by dividing the CI value at each time point by the CI at the time of addition of the eggs was ascertained 
with the assistance of the RTCA Software 1.2 (ACEA). Normalized CI values were imported into Microsoft Excel 
for analysis where the cellular growth of cells exposed to the eggs was expressed as the percentage of the normal-
ized CI of cells cultured with indicated eggs compared to (i.e. divided by) that of control cells cultured in 1/20 
diluted media. (Control cells growth rate = 100%.) Statistical significance among the groups was assessed using 
Analysis of Variance (ANOVA) and Student’s t-test. P values of ≤0.05 were considered significant.
Epithelial cells co-cultured with schistosome eggs. H69 and HCV29 cells were seeded into wells 
of 6-well plates at a cell density ranging from 2.5 × 105 and 3 × 105 cells/well in 2 ml media and cultured until 
80–90% confluence (usually 12–24 h) before being co-cultured with schistosome eggs. Before the addition of the 
eggs, the cells were starved for at least four hours in 1/20 dilution with 1% PS of their respective media. Thereafter, 
wells containing starved cells were fitted with Corning 6 Well Transwell Inserts, 0.4 μm PET Membrane, TC 
Treated, and ~2.5 × 103 eggs of S. mansoni or S. haematobium were added to the Transwell. The Transwell ensured 
exposure of the cells to the excretory-secretory products (ES) of the eggs. Transwells were removed after two 
hours (‘early time point’) or 24 hours (‘late time point’) at which time cells were harvested for RNA isolation and 
gene expression analysis, or protein quantification. Cells not exposed to eggs but otherwise cultured similarly 
served as the control.
ELISA-based quantification of selected human proteins. Human urothelial HCV29 cells exposed 
to schistosome eggs or control cells exposed to no eggs for 2 or 24 hours in 6 -well plates in triplicates were har-
vested for protein isolation and quantification of selected human proteins using commercially available ELISA 
kits (Abcam). Based on the qPCR gene array findings three human proteins were measured by ELISA, i.e. BAX 
(https://www.abcam.com/human-bax-elisa-kit-ab199080.html), MASPIN (SERPIN B5) (https://www.abcam.
com/human-maspin-elisa-kitab218269.html), and P53 (https://www.abcam.com/human-p53-elisa-kit-ab171571.
html). At the indicated time points the cell supernatant was removed and the cells washed twice with 1x PBS. The 
cells were exposed to 20μl of protease inhibitor cocktail (Calbiochem 539137), collected using a cell scraper and 
transferred to a 1.5 ml tube. One ml of 1xPBS was used to rinse the well and transferred to the corresponding 
tube that was kept on ice all the time. Thereafter, the cells were pelleted at 400 × g, for 10 min at 4 °C, and the cell 
pellet resuspended in 1 ml of 1xPBS. The cells were centrifugated as above and the pellet resuspended in 60μl 
of CEB PTR buffer (ELISA Abcam kit). The protein concentration for each sample was determined using the 
bicinchoninic acid assay (BCA kit, Pierce, Rockford, IL), and the input total protein concentration was 20 ng/
ml for each reaction. The ELISA assays were performed following the manufacturer’s instructions. In brief, a 
colorimetric reaction became apparent after the addition of the TMB substrate to the protein lysate mixed with 
the protein-specific antibodies in a ‘sandwich’ format in a 96-well plate. Standard curves for each target protein 
were included in the assay as positive control and as reference for the quantification. Optical densities at 450 nm 
were determined using a spectrophotometer plate reader, and the raw readouts were exported and analysed using 
Graphpad Prism software. Three biological replicates with three technical replicates per biological repeat were 
carried out. Levels of MASPIN were below the level of detection of the kit.
RNA isolation and gene arrays analysis. Total RNA was isolated from cells using the miRNeasy Mini 
kit (Qiagen) following the manufacturer’s instruction. Briefly, 700 μl of QIAzol Lysis Reagent was added to each 
cell pellet and homogenized using a sterile micropestle (Kontes, Vineland NJ). Chloroform, 140 μl, was added, 
contents mixed, and clarified at 12,000 × g, 15 min at 4 °C. The upper aqueous phase was transferred to a new 
tube containing 100% ethanol; subsequent washes through a spin column and on-column DNase treatment were 
performed. RNA was eluted in ~35 μl of RNAse-free water, and concentration, purity and integrity evaluated 
using spectrophotometry (Nanodrop 1000) and Agilent 2100 Bioanalyzer. The RNA preps were stored at −80 °C 
until processed for cDNA synthesis using 300 to 500 ng of total RNA and qPCR following the PrimerPCR Assay 
protocol (Bio-Rad). The qPCR experiments were performed using a Bio-Rad iCycler iQ5 with an initial activation 
step of 95 °C for 10 min followed by 40 cycles of 95 °C for 10 sec and 60 °C for 1 min. A melting curve analysis from 
55 °C to 95 °C and 0.5 °C temperature increment every 30 sec was included at the end of the run. Specific gene 
arrays were selected; (1) Oncogenes and tumor suppressor genes (SAB Target List), http://www.bio-rad.com/
en-uk/prime-pcr-assays/predesigned-plate/sybr-green-oncogenes-tumor-suppressor-genes-sab-target-list-h96; 
(2) Epithelial to mesenchymal transition (EMT) (SAB Target List), http://www.bio-rad.com/en-uk/
prime-pcr-assays/predesigned-plate/sybr-green-epithelial-mesenchymal-transition-emt-sab-target-list-h96; 
and (3) Apoptosis (SAB Target List), http://www.bio-rad.com/en-uk/prime-pcr-assays/predesigned-plate/
sybr-green-apoptosis-sab-target-list-h96. These predesigned arrays allow the detection of 84 genes along with 
controls that include DNA contamination control, positive PCR control, RNA quality control, and reverse tran-
scription control. Ct values were exported and analyzed using Prime PCR Analysis software (http://www.bio-rad.
com/en-us/sku/genestudy-1-0-030-1023-primepcr-analysis-software), and relative quantitation performed using 
the 2−ΔΔCt method employing a panel of three housekeeping genes: glyceraldehyde-3-phosphate dehydrogenase, 
hypoxanthine phosphoribosyltransferase 1, and TATA-box binding protein. Control groups (cells exposed to 
media alone) were used as calibrator samples. Three biological replicates were performed. Venn diagrams were 
performed using the online free tool http://bioinformatics.psb.ugent.be/webtools/Venn/.
Gene pathway analysis. Functional pathway and upstream regulatory analysis (URA) of differentially 
expressed genes (DEGs) was performed with the assistance of Ingenuity Pathway Analysis (IPA QIAGEN 
Redwood City, www.qiagen.com/ingenuity) software. In brief, the dataset from the real time PCR analysis was 
1 2Scientific RepoRts |         (2019) 9:10731  | https://doi.org/10.1038/s41598-019-46917-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
imported into the IPA to define the genes which were significantly up and downregulated and P-values were set 
up equal or lower than 0.05 as the significant threshold. IPA includes Benjamini-Hochberg analysis of multiple 
testing correction based on the Fisher’s exact test p-value to calculate false discovery rate between multiple com-
parisons. Additionally, IPA uses Right-Tailed Fisher’s Exact Test to determine which biological functions and 
canonical pathways are significantly associated with the genes of interest compared with the whole Ingenuity 
knowledge base (http://www.ingenuity.com/science/knowledge-base). In addition, to determine predictions 
about upstream processes, IPA provides a z-score, where z-scores >2 or <−2 are considered significant. This 
analysis considers the directional effect of one molecule or process on another, and the direction of this change in 
the dataset, i.e. it represents the statistical measure of the correlation between the direction of the change (up- or 
down- regulation) and gene expression (https://chhe.research.ncsu.edu/wordpress/wp-content/uploads/2015/10/
IPA-Data-Analysis-training-slides-2016_04.pdf). The IPA analysis also enables the identification of biological 
networks, global functions and functional pathways for a particular dataset. The analysis estimates the signif-
icance of the genes in the network, the other genes with which it interacts, and how the products of the genes 
directly or indirectly act on each other, including those not involved in the analysis (determining up stream 
regulators). The networks are ranked depending on their number of significantly differentially expressed genes 
and associated relevant diseases. Genes in the network are represented as nodes, and the biological relationship 
between two nodes is represented as an edge (line). The intensity of the node color is related to the fold change of 
the differentially expressed genes, i.e. upregulated or downregulated genes indicated in red or green, respectively. 
All edges are supported by at least one published report and/or canonical definition in the Ingenuity Pathways 
Knowledge Base.
Statistical analysis. For gene expression studies, fold change values of significantly DEGs (P ≤ 0.05) from 
the four analyzed gene arrays (above) using Prime PCR Analysis were exported to GraphPad Prism 6.02, pooled 
and plotted in a volcano plot. The genes with P-value ≤ 0.05 and a significant fold-change >1.5 or <−1.5 for 
upregulated and downregulated genes, respectively, were included in subsequent analyses.
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